Bacteria are good at evolving to evade efforts to destroy it. But building defenses like antibiotic resistance drains limited ...

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...

Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...

Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...

Arthur Tzianabos, CEO, Lifordi Immunotherapeutics, spoke with PharmTech about the company’s immune-directed antibody-drug ...

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ent ...

Would it be possible to control and even reverse the flow of time in a laboratory setting? While taking a trip back through ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

The research group of Professor Chuandong Dou at the State Key Laboratory of Supramolecular Structure and Materials, Jilin University, recently ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...